JO
BEAT

John Overdeck’s BioTelemetry, Inc. BEAT Stock Holding History

John Overdeck’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,600
Closed -$259K – 4151
2019
Q4 		$259K Sell
5,600
-8,200
-59% -$355K ﹤0.01% 3291
2019
Q3 		$562K Sell
13,800
-900
-6% -$38.9K ﹤0.01% 2471
2019
Q2 		$708K Buy
+14,700
New +$773K ﹤0.01% 2227

Other funds holding BEAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return

John Overdeck's BEAT Position: Q4 2019 in Review

John Overdeck sold out of BioTelemetry, Inc. (BEAT) in Q4 2019, closing a stake of 5,363 shares — an estimated $232K sold.

John Overdeck first reported a position in BEAT in Q2 2015 and held it in 13 quarters. The position peaked at $7.48M in Q1 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q4 2019.

  • John Overdeck reported no remaining BioTelemetry, Inc. position as of Q4 2019 after selling out during the quarter.
  • John Overdeck sold 5,363 BioTelemetry, Inc. shares in Q4 2019, an estimated $232K.
  • John Overdeck first reported a position in BioTelemetry, Inc. in Q2 2015 and held it in 13 quarters.
  • John Overdeck's BioTelemetry, Inc. position peaked at $7.48M in Q1 2019.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2019.

Based on Two Sigma Investments's 13F filing for Q4 2019, filed 14 Feb 2020.